Evidence map›Paper›PMID 25013611›Full record

ArticleInternational journal of organ transplantation medicine2011

Association of the Co-stimulatory Molecules Polymorphisms with CMV Infection in Liver Transplant Recipients.

M H Karimi, M Motazedian, B Geramizadeh, S Nikeghbalian, R Yaghobi, F Abedi, M Hossin Aghdaee, N Azarpira, M Arabpour, Z Malekpour and 1 more

Open access · greenAbstract read
In one paragraph

Article in International journal of organ transplantation medicine, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed, 1 pooled it
0.6field-weighted citation impact, top 31% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 1 synthesis or guideline pooled it, 9 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 2 institutions in 1 country.

M H KarimiTransplant Research Center, Shiraz University of Medical Sciences, Shiraz, Iran.
M MotazedianIslamic Azad University, Jahrom branch, Jahrom, Iran.
B GeramizadehTransplant Research Center, Shiraz University of Medical Sciences, Shiraz, Iran.
S NikeghbalianTransplant Research Center, Shiraz University of Medical Sciences, Shiraz, Iran.
R YaghobiTransplant Research Center, Shiraz University of Medical Sciences, Shiraz, Iran.
F AbediIslamic Azad University, Jahrom branch, Jahrom, Iran.
M Hossin AghdaeeTransplant Research Center, Shiraz University of Medical Sciences, Shiraz, Iran.
N AzarpiraTransplant Research Center, Shiraz University of Medical Sciences, Shiraz, Iran.
M ArabpourTransplant Research Center, Shiraz University of Medical Sciences, Shiraz, Iran.
Z MalekpourTransplant Research Center, Shiraz University of Medical Sciences, Shiraz, Iran.
M NamayandehTransplant Research Center, Shiraz University of Medical Sciences, Shiraz, Iran.
Shiraz University of Medical Sciences · IRIslamic Azad University, Jahrom Branch · IR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundCo-stimulatory molecules play a critical role in regulating T-cell function during CMV infection after liver transplantation.

objectiveTo investigate the relationship between the polymorphisms of the co-stimulatory genes and the susceptibility to CMV infection after liver transplantation.

methodsSingle nucleotide polymorphisms (SNPs) in PD-1 gene (PD1.1 A/G, PD1.3 A/G, PD1.9 C/T) ICOS (-693 A/G, 1720 C/T), CTLA-4 gene (318 C/T, 1722 T/C, 1661 A/G, 49 A/G) and CD28 (+17 C/T) were analyzed by PCR-RFLP in 70 liver transplant patients. CMV infection was determined in these patients by antigenemia test.

resultsCTLA-4 49G showed significant association with CMV infection (p=0.03, OR=3.82, 95% CI: 0-3.5; p=0.01, OR=004, 95% CI: 0-1.3). G and T alleles in CTLA-4 gene (318 C/T and 1661 A/G) (p=0.03, OR=0, 95% CI: 0-3.5; p=0.01, OR=0.04, 95% CI: 0-1.3) were significantly higher in CMV-infected rejector group.

conclusionCTLA-4 have significant role in CMV pathogenesis and rejection among CMV-positive liver transplant patients.

Indexed as

CMVLiverpathogenesispolymorphismsRejectionTransplant recipient

Identifiers

PMID25013611
PMCPMC4089271
OpenAlexW194170075

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.